Skip to main content

Profile hero

Profile details

About Shannon O'Hara

Shannon is an Associate in our New York office supporting our global transactions team.

Recent work

  • AstraZeneca on its acquisition of Gracell Biotechnologies.
  • Merz Therapeutics on its $185 million pending acquisition of the assets of Acorda Therapeutics, Inc. through a court structured 363 sale process under the U.S. Bankruptcy Code.
  • Johnson & Johnson on its $13.1 billion pending acquisition of Shockwave Medical, Inc.



  • Duke University School of Law, J.D., 2023
  • Duke University Nicholas School of the Environment, M.E.M., Ecotoxicology, 2023
  • University of California, Berkeley, B.S., Molecular Environmental Biology, 2019

Bar Admission

  • New York, 2024
  • Pennsylvania, 2023